BIO-TECHNE Corp TECH

About BIO-TECHNE Corp (TECH): stock profile, AI score and financials

BIO-TECHNE Corp (TECH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TECH at 58.7/100 on a composite quality score built from its SEC filings, placing it at rank #985 of 2,925 stocks — the top half of the AI-ranked universe. TECH scores in the top quartile across profitability (78.7), balance sheet strength (77.1), earnings quality (77.1). Areas of concern include revenue growth (32.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 29.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2026), BIO-TECHNE Corp reports quarterly revenue of $321.2M, net income of $54.6M, an operating margin of 23.1%. Top institutional holders of TECH by reported 13-F value include BlackRock, FMR, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. TECH trades on the Nasdaq exchange and files with the SEC under CIK 842023. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TECH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BIO-TECHNE Corp directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 842023 →